{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T19:58:48Z","timestamp":1781553528069,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["RP-PG-0608-10038"],"award-info":[{"award-number":["RP-PG-0608-10038"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004571","name":"Minist\u00e8re des Affaires Sociales et de la Sant\u00e9","doi-asserted-by":"publisher","award":["AOR12156"],"award-info":[{"award-number":["AOR12156"]}],"id":[{"id":"10.13039\/501100004571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004571","name":"Minist\u00e8re des Affaires Sociales et de la Sant\u00e9","doi-asserted-by":"publisher","award":["AOR12156"],"award-info":[{"award-number":["AOR12156"]}],"id":[{"id":"10.13039\/501100004571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["PRE-839\/13"],"award-info":[{"award-number":["PRE-839\/13"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-025-07271-2","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T15:42:45Z","timestamp":1744040565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Management and outcomes of women with placenta accreta spectrum grade 3: an INOSS multicountry multiperiod population-based study"],"prefix":"10.1186","volume":"25","author":[{"given":"Anne","family":"Pinton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ornaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Sentilhes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Donati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Kayem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Deneux-Tharaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"issue":"3","key":"7271_CR1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ajog.2022.02.038","volume":"227","author":"E Jauniaux","year":"2022","unstructured":"Jauniaux E, Jurkovic D, Hussein AM, Burton GJ. New insights into the etiopathology of placenta accreta spectrum. Am J Obstet Gynecol. 2022;227(3):384\u201391.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"7271_CR2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ijgo.12761","volume":"146","author":"E Jauniaux","year":"2019","unstructured":"Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, Fox KA, Collins S. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet off Organ Int Fed Gynaecol Obstet. 2019;146(1):20\u20134.","journal-title":"Int J Gynaecol Obstet off Organ Int Fed Gynaecol Obstet"},{"issue":"2","key":"7271_CR3","doi-asserted-by":"crossref","first-page":"e1931","DOI":"10.1016\/j.ajog.2018.04.049","volume":"219","author":"L Marcellin","year":"2018","unstructured":"Marcellin L, Delorme P, Bonnet MP, Grange G, Kayem G, Tsatsaris V, et al. Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta. Am J Obstet Gynecol. 2018;219(2):e1931\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"7271_CR4","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/1471-0528.17169","volume":"129","author":"SJ McCall","year":"2022","unstructured":"McCall SJ, Deneux-Tharaux C, Sentilhes L, Ramakrishnan R, Collins SL, Seco A, et al. Placenta accreta spectrum - variations in clinical practice and maternal morbidity between the UK and France: a population-based comparative study. BJOG Int J Obstet Gynaecol. 2022;129(10):1676\u201385.","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"1","key":"7271_CR5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/1471-0528.12405","volume":"121","author":"KE Fitzpatrick","year":"2014","unstructured":"Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study. BJOG Int J Obstet Gynaecol. 2014;121(1):62\u201370. discussion 70\u201371.","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"7271_CR6","doi-asserted-by":"crossref","unstructured":"Kayem G, Seco A, Beucher G, Dupont C, Branger B, Crenn Hebert C et al. Clinical profiles of Placenta Accreta Spectrum: the PACCRETA Population-based study. BJOG Int J Obstet Gynaecol. 2021.","DOI":"10.1111\/1471-0528.16647"},{"issue":"8","key":"7271_CR7","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/1471-0528.13547","volume":"123","author":"L Thurn","year":"2016","unstructured":"Thurn L, Lindqvist PG, Jakobsson M, Colmorn LB, Klungsoyr K, Bjarnad\u00f3ttir RI, et al. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the nordic countries. BJOG Int J Obstet Gynaecol. 2016;123(8):1348\u201355.","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"3","key":"7271_CR8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ijgo.12407","volume":"140","author":"E Jauniaux","year":"2018","unstructured":"Jauniaux E, Chantraine F, Silver RM, Langhoff-Roos J. FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology. Int J Gynecol Obstet. 2018;140(3):265\u201373.","journal-title":"Int J Gynecol Obstet"},{"key":"7271_CR9","doi-asserted-by":"crossref","unstructured":"Zuckerwise LC, Craig AM, Newton JM, Zhao S, Bennett KA, Crispens MA. Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum. Am J Obstet Gynecol. 2020;222(2):179.e1-179.e9.","DOI":"10.1016\/j.ajog.2019.08.035"},{"issue":"6","key":"7271_CR10","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0002-9378(96)70117-5","volume":"175","author":"JM O\u2019Brien","year":"1996","unstructured":"O\u2019Brien JM, Barton JR, Donaldson ES. The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol. 1996;175(6):1632\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"7271_CR11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ijgo.12410","volume":"140","author":"L Sentilhes","year":"2018","unstructured":"Sentilhes L, Kayem G, Chandraharan E, Palacios-Jaraquemada J, Jauniaux E, FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: conservative management. Int J Gynaecol Obstet off Organ Int Fed Gynaecol Obstet. 2018;140(3):291\u20138.","journal-title":"Int J Gynaecol Obstet off Organ Int Fed Gynaecol Obstet"},{"issue":"3","key":"7271_CR12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ijgo.12409","volume":"140","author":"L Allen","year":"2018","unstructured":"Allen L, Jauniaux E, Hobson S, Papillon-Smith J, Belfort MA, FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: nonconservative surgical management. Int J Gynaecol Obstet off Organ Int Fed Gynaecol Obstet. 2018;140(3):281\u201390.","journal-title":"Int J Gynaecol Obstet off Organ Int Fed Gynaecol Obstet"},{"key":"7271_CR13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.placenta.2020.06.003","volume":"97","author":"KL Huang","year":"2020","unstructured":"Huang KL, Leung-Chit Tsang L, Cheng YF, Huang FJ, Fu HC, Kung FT, et al. Planned conservative management of placenta increta and percreta with prophylactic transcatheter arterial embolization and leaving placenta in situ for women who desire fertility preservation. Placenta. 2020;97:51\u20137.","journal-title":"Placenta"},{"issue":"1","key":"7271_CR14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijoa.2010.08.006","volume":"20","author":"S Thon","year":"2011","unstructured":"Thon S, McLintic A, Wagner Y. Prophylactic endovascular placement of internal iliac occlusion balloon catheters in parturients with placenta accreta: a retrospective case series. Int J Obstet Anesth. 2011;20(1):64\u201370.","journal-title":"Int J Obstet Anesth"},{"issue":"5","key":"7271_CR15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/01443615.2017.1291588","volume":"37","author":"L Xie","year":"2017","unstructured":"Xie L, Wang Y, Luo FY, Man YC, Zhao XL. Prophylactic use of an infrarenal abdominal aorta balloon catheter in pregnancies complicated by placenta accreta. J Obstet Gynaecol J Inst Obstet Gynaecol. 2017;37(5):557\u201361.","journal-title":"J Obstet Gynaecol J Inst Obstet Gynaecol"},{"key":"7271_CR16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejogrb.2014.05.007","volume":"179","author":"G Cali","year":"2014","unstructured":"Cali G, Forlani F, Giambanco L, Amico ML, Vallone M, Puccio G, et al. Prophylactic use of intravascular balloon catheters in women with placenta accreta, increta and percreta. Eur J Obstet Gynecol Reprod Biol. 2014;179:36\u201341.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"12","key":"7271_CR17","doi-asserted-by":"crossref","first-page":"e52893","DOI":"10.1371\/journal.pone.0052893","volume":"7","author":"KE Fitzpatrick","year":"2012","unstructured":"Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. Incidence and risk factors for placenta accreta\/increta\/percreta in the UK: a national case-control study. PLoS ONE. 2012;7(12):e52893.","journal-title":"PLoS ONE"},{"issue":"6","key":"7271_CR18","doi-asserted-by":"crossref","first-page":"e0252654","DOI":"10.1371\/journal.pone.0252654","volume":"16","author":"S Ornaghi","year":"2021","unstructured":"Ornaghi S, Maraschini A, Donati S, Group on behalf of TROSSW. Characteristics and outcomes of pregnant women with placenta accreta spectrum in Italy: a prospective population-based cohort study. PLoS ONE. 2021;16(6):e0252654.","journal-title":"PLoS ONE"},{"issue":"3","key":"7271_CR19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1471-0528.2005.00609.x","volume":"112","author":"M Knight","year":"2005","unstructured":"Knight M, Kurinczuk JJ, Tuffnell D, Brocklehurst P. The UK Obstetric Surveillance System for rare disorders of pregnancy. BJOG Int J Obstet Gynaecol. 2005;112(3):263\u20135.","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"7271_CR20","unstructured":"Praevia RCOGP. Placenta Praevia Accreta and Vasa Praevia: Diagnosis and Management (Green-top Guideline No. 27). Available from: https:\/\/www.rcog.org.uk\/guidance\/browse-all-guidance\/green-top-guidelines\/placenta-praevia-placenta-praevia-accreta-and-vasa-praevia-diagnosis-and-management-green-top-guideline-no-27\/"},{"key":"7271_CR21","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. H\u00e9morragies du post-partum imm\u00e9diat. Available from: https:\/\/www.has-sante.fr\/jcms\/c_272417\/fr\/hemorragies-du-post-partum-immediat"},{"issue":"4","key":"7271_CR22","first-page":"363","volume":"55","author":"S Donati","year":"2019","unstructured":"Donati S, Maraschini A, Dell\u2019Oro S, Lega I, D\u2019Aloja P, Regional Maternal Mortality Working Group. The way to move beyond the numbers: the lesson learnt from the Italian Obstetric Surveillance System. Ann Ist Super Sanita. 2019;55(4):363\u201370.","journal-title":"Ann Ist Super Sanita"},{"issue":"2","key":"7271_CR23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/aogs.12295","volume":"93","author":"C Clausen","year":"2014","unstructured":"Clausen C, L\u00f6nn L, Langhoff-Roos J. Management of placenta percreta: a review of published cases. Acta Obstet Gynecol Scand. 2014;93(2):138\u201343.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"7271_CR24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/ajo.12149","volume":"54","author":"S Pather","year":"2014","unstructured":"Pather S, Strockyj S, Richards A, Campbell N, de Vries B, Ogle R. Maternal outcome after conservative management of placenta percreta at caesarean section: a report of three cases and a review of the literature. Aust N Z J Obstet Gynaecol. 2014;54(1):84\u20137.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"4","key":"7271_CR25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4274\/jtgga.galenos.2020.2020.0106","volume":"21","author":"K Khoiwal","year":"2020","unstructured":"Khoiwal K, Gaurav A, Kapur D, Kumari O, Sharma P, Bhandari R, et al. Placenta percreta - a management dilemma: an institutional experience and review of the literature. J Turk Ger Gynecol Assoc. 2020;21(4):228\u201335.","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"7271_CR26","doi-asserted-by":"crossref","unstructured":"Bartels HC, Downey P, Brennan DJ. Looking back to look forward: has the time arrived for active management of obstetricians in placenta accreta spectrum? Int J Gynaecol Obstet off Organ Int Fed Gynaecol Obstet. 2024.","DOI":"10.1002\/ijgo.15826"},{"key":"7271_CR27","doi-asserted-by":"crossref","unstructured":"Shamshirsaz AA, Fox KA, Erfani H, Clark SL, Salmanian B, Baker BW et al. Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time. Am J Obstet Gynecol. 2017;216(6):612.e1-612.e5.","DOI":"10.1016\/j.ajog.2017.02.016"},{"key":"7271_CR28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bpobgyn.2019.04.006","volume":"61","author":"E Jauniaux","year":"2019","unstructured":"Jauniaux E, Hussein AM, Fox KA, Collins SL. New evidence-based diagnostic and management strategies for placenta accreta spectrum disorders. Best Pract Res Clin Obstet Gynaecol. 2019;61:75\u201388.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"7271_CR29","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/uog.19070","volume":"52","author":"D Buca","year":"2018","unstructured":"Buca D, Liberati M, Cal\u00ec G, Forlani F, Caisutti C, Flacco ME, et al. Influence of prenatal diagnosis of abnormally invasive placenta on maternal outcome: systematic review and meta-analysis. Ultrasound Obstet Gynecol off J Int Soc Ultrasound Obstet Gynecol. 2018;52(3):304\u20139.","journal-title":"Ultrasound Obstet Gynecol off J Int Soc Ultrasound Obstet Gynecol"},{"issue":"16","key":"7271_CR30","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMcp1709324","volume":"378","author":"RM Silver","year":"2018","unstructured":"Silver RM, Branch DW. Placenta Accreta Spectrum. N Engl J Med. 2018;378(16):1529\u201336.","journal-title":"N Engl J Med"},{"issue":"2 Pt 1","key":"7271_CR31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/AOG.0b013e3182051db2","volume":"117","author":"AG Eller","year":"2011","unstructured":"Eller AG, Bennett MA, Sharshiner M, Masheter C, Soisson AP, Dodson M, et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol. 2011;117(2 Pt 1):331\u20137.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"7271_CR32","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1016\/j.ajog.2009.08.037","volume":"202","author":"T Angstmann","year":"2010","unstructured":"Angstmann T, Gard G, Harrington T, Ward E, Thomson A, Giles W. Surgical management of placenta accreta: a cohort series and suggested approach. Am J Obstet Gynecol. 2010;202(1):e381\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"7271_CR33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/AOG.0b013e3181c4f12a","volume":"115","author":"CR Warshak","year":"2010","unstructured":"Warshak CR, Ramos GA, Eskander R, Benirschke K, Saenz CC, Kelly TF, et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol. 2010;115(1):65\u20139.","journal-title":"Obstet Gynecol"},{"issue":"12","key":"7271_CR34","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1111\/j.1537-2995.2011.03205.x","volume":"51","author":"B Stotler","year":"2011","unstructured":"Stotler B, Padmanabhan A, Devine P, Wright J, Spitalnik SL, Schwartz J. Transfusion requirements in obstetric patients with placenta accreta. Transfus (Paris). 2011;51(12):2627\u201333.","journal-title":"Transfus (Paris)"},{"issue":"6","key":"7271_CR35","doi-asserted-by":"crossref","first-page":"e6281","DOI":"10.1016\/j.ajog.2010.03.021","volume":"202","author":"MS Hoffman","year":"2010","unstructured":"Hoffman MS, Karlnoski RA, Mangar D, Whiteman VE, Zweibel BR, Lockhart JL, et al. Morbidity associated with nonemergent hysterectomy for placenta accreta. Am J Obstet Gynecol. 2010;202(6):e6281\u20135.","journal-title":"Am J Obstet Gynecol"},{"key":"7271_CR36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bpobgyn.2020.07.011","volume":"72","author":"A Fonseca","year":"2021","unstructured":"Fonseca A, Ayres de Campos D. Maternal morbidity and mortality due to placenta accreta spectrum disorders. Best Pract Res Clin Obstet Gynaecol. 2021;72:84\u201391.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"6","key":"7271_CR37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000447556","volume":"81","author":"M Farasatinasab","year":"2016","unstructured":"Farasatinasab M, Moghaddas A, Dashti-Khadivaki S, Raoofi Z, Nasiripour S. Management of abnormal placenta implantation with methotrexate: a review of published data. Gynecol Obstet Invest. 2016;81(6):481\u201396.","journal-title":"Gynecol Obstet Invest"},{"issue":"3","key":"7271_CR38","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/AOG.0b013e3181d066d4","volume":"115","author":"L Sentilhes","year":"2010","unstructured":"Sentilhes L, Ambroselli C, Kayem G, Provansal M, Fernandez H, Perrotin F, et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol. 2010;115(3):526\u201334.","journal-title":"Obstet Gynecol"},{"issue":"25","key":"7271_CR39","first-page":"7514","volume":"35","author":"C Gregoir","year":"2022","unstructured":"Gregoir C, De Becker B, Hauspy J, Vanderheyden T, Loquet P. The use of methotrexate in conservative treatment of placenta accreta spectrum disorders. J Matern-Fetal Neonatal Med off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2022;35(25):7514\u20137.","journal-title":"J Matern-Fetal Neonatal Med off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet"},{"issue":"10","key":"7271_CR40","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/aogs.13892","volume":"99","author":"AF Kallianidis","year":"2020","unstructured":"Kallianidis AF, Maraschini A, Danis J, Colmorn LB, Deneux-Tharaux C, Donati S, et al. Epidemiological analysis of peripartum hysterectomy across nine European countries. Acta Obstet Gynecol Scand. 2020;99(10):1364\u201373.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"7271_CR41","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/jcpt.13120","volume":"45","author":"S Matsubara","year":"2020","unstructured":"Matsubara S, Takahashi H, Takei Y, Imai Y. Methotrexate for placenta accreta spectrum disorders: is it needed? J Clin Pharm Ther. 2020;45(2):399\u2013400.","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"7271_CR42","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/1471-0528.15349","volume":"126","author":"ERM Jauniaux","year":"2019","unstructured":"Jauniaux ERM, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, et al. Placenta Praevia and Placenta Accreta: diagnosis and management. BJOG Int J Obstet Gynaecol. 2019;126(1):e1\u201348.","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"5","key":"7271_CR43","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jvir.2018.12.007","volume":"30","author":"M Wang","year":"2019","unstructured":"Wang M, Ballah D, Wade A, Taylor AG, Rizzuto G, Li B, et al. Uterine artery embolization following cesarean delivery but prior to hysterectomy in the management of patients with invasive placenta. J Vasc Interv Radiol JVIR. 2019;30(5):687\u201391.","journal-title":"J Vasc Interv Radiol JVIR"},{"issue":"4","key":"7271_CR44","doi-asserted-by":"crossref","first-page":"e4421","DOI":"10.1016\/j.ajog.2021.07.001","volume":"225","author":"DJ Melber","year":"2021","unstructured":"Melber DJ, Berman ZT, Jacobs MB, Picel AC, Conturie CL, Zhang-Rutledge K, et al. Placenta Accreta Spectrum Treatment with Intraoperative Multivessel Embolization: the PASTIME protocol. Am J Obstet Gynecol. 2021;225(4):e4421\u201344210.","journal-title":"Am J Obstet Gynecol"},{"key":"7271_CR45","doi-asserted-by":"crossref","unstructured":"Sentilhes L, Seco A, Azria E, Beucher G, Bonnet MP, Branger B et al. Conservative management or cesarean hysterectomy for placenta accreta spectrum: the PACCRETA prospective study. Am J Obstet Gynecol. 2022;226(6):839.e1-839.e24.","DOI":"10.1016\/j.ajog.2021.12.013"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07271-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-07271-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07271-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T06:34:50Z","timestamp":1744180490000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-07271-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7271"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-07271-2","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For the UK, this study was approved by the London Research Ethics Committee (ref. 10\/H0717\/20). The need for consent to participate was also waived by the ethics committee that approved this study. Data ware fully anonymized before being accessed and analyzed. For France, PACCRETA The appropriate ethics committees (Consultative Committee on the Treatment of Data on Personal Health for Research Purposes \u2013 reference no. AOR12156; 12\/19\/2013, and the Committee for the Protection of People Participating in Biomedical Research \u2013 reference CPP 13\u2013017; 05\/28\/2013), and the National Data Protection Authority (CNIL no. DR-2013-427; 12\/20\/2013) approved the study. The need for consent to participate was also waived by the ethics committee that approved this study. Data ware fully anonymized before being accessed and analyzed. For Italy, the study was approved by the Committee of the Italian National Institute of Health (Port. PRE-839\/13). The need for consent to participate was also waived by the ethics committee that approved this study. Data ware fully anonymized before being accessed and analyzed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors consent to the publication of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"401"}}